Literature DB >> 17651159

Medical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005.

Jemima E Mellerio1, Madeline Weiner, Jacqueline E Denyer, Elizabeth I Pillay, Anne W Lucky, Anna Bruckner, Francis Palisson.   

Abstract

Mesh：

Year:  2007        PMID： 17651159     DOI： 10.1111/j.1365-4632.2007.03316.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  15 in total

1.  Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica.

Authors:  L Moretti; A Notarnicola; A Panella; L Garofalo; R Garofalo; A Santamato; B Moretti
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  A consensus approach to wound care in epidermolysis bullosa.

Authors:  Elena Pope; Irene Lara-Corrales; Jemima Mellerio; Anna Martinez; Gregory Schultz; Robert Burrell; Laurie Goodman; Patricia Coutts; John Wagner; Upton Allen; Gary Sibbald
Journal:  J Am Acad Dermatol       Date:  2012-03-02       Impact factor: 11.527

3.  Epidermolysis bullosae.

Authors:  A N Prasad
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.

Authors:  C L Ebens; J A McGrath; K Tamai; A Hovnanian; J E Wagner; M J Riddle; D R Keene; T E DeFor; R Tryon; M Chen; D T Woodley; K Hook; J Tolar
Journal:  Br J Dermatol       Date:  2019-06-28       Impact factor: 9.302

5.  Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.

Authors:  Velina S Atanasova; Celine Pourreyron; Mehdi Farshchian; Michael Lawler; Christian A Brown; Stephen A Watt; Sheila Wright; Michael Warkala; Christina Guttmann-Gruber; Josefina Piñón Hofbauer; Ignacia Fuentes; Marco Prisco; Elham Rashidghamat; Cristina Has; Julio C Salas-Alanis; Francis Palisson; Alain Hovnanian; John A McGrath; Jemima E Mellerio; Johann W Bauer; Andrew P South
Journal:  Clin Cancer Res       Date:  2019-03-07       Impact factor: 12.531

6.  Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.

Authors:  Jakub Tolar; Lily Xia; Megan J Riddle; Chris J Lees; Cindy R Eide; Ron T McElmurry; Matthias Titeux; Mark J Osborn; Troy C Lund; Alain Hovnanian; John E Wagner; Bruce R Blazar
Journal:  J Invest Dermatol       Date:  2010-12-02       Impact factor: 8.551

7.  Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.

Authors:  John E Wagner; Akemi Ishida-Yamamoto; John A McGrath; Maria Hordinsky; Douglas R Keene; David T Woodley; Mei Chen; Megan J Riddle; Mark J Osborn; Troy Lund; Michelle Dolan; Bruce R Blazar; Jakub Tolar
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

8.  No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.

Authors:  Karin J Purdie; Celine Pourreyron; Hiva Fassihi; Rodrigo Cepeda-Valdes; John W Frew; Andreas Volz; Sönke J Weissenborn; Herbert Pfister; Charlotte M Proby; Leena Bruckner-Tuderman; Dedee F Murrell; Julio C Salas-Alanis; John A McGrath; Irene M Leigh; Catherine A Harwood; Andrew P South
Journal:  J Invest Dermatol       Date:  2010-08-26       Impact factor: 8.551

9.  Non-endoscopic percutaneous gastrostomy placement in children with recessive dystrophic epidermolysis bullosa.

Authors:  Wolfgang Stehr; Michael K Farrell; Anne W Lucky; Neil D Johnson; John M Racadio; Richard G Azizkhan
Journal:  Pediatr Surg Int       Date:  2007-12-20       Impact factor: 1.827

10.  Access to wound dressings for patients living with epidermolysis bullosa - an Australian perspective.

Authors:  Louise J Stevens
Journal:  Int Wound J       Date:  2012-11-22       Impact factor: 3.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.